# A1 Diagnosis

> A1 Diagnosis is a US-based medical diagnostics company developing a blood-based risk assessment platform for age-related macular degeneration (AMD).

A1 Diagnosis uses AI and blood biomarker analysis to help identify signals associated with AMD risk years before vision symptoms appear. The platform aims to enable earlier, more proactive eye care.

## Company Details

- **Founded:** 2024
- **Location:** Orange County, California, USA
- **Website:** https://a1diagnosis.com
- **Contact:** ozgul@A1Diagnosis.com
- **Stage:** Pre-clinical validation
- **Regulatory Pathway:** Laboratory Developed Test (LDT)

## Founder

- **Dr. Mustafa Ozgul, MD** — Founder & CEO. Six years of AMD research at UC Irvine Gavin Herbert Eye Institute. 15 publications in AMD and retinal research (4 peer-reviewed journal articles, 11 ARVO conference abstracts). LinkedIn: https://www.linkedin.com/in/drozgul

## Key Pages

- [Home](https://a1diagnosis.com/): Overview of A1 Diagnosis and the proactive vision risk analysis platform
- [About](https://a1diagnosis.com/about.html): Purpose, leadership, history, corporate impact, and collaborations
- [What is AMD?](https://a1diagnosis.com/what-is-amd.html): Education on age-related macular degeneration
- [How It Works](https://a1diagnosis.com/how-it-works.html): How the blood-based AMD risk assessment works
- [Proactive Vision Platform](https://a1diagnosis.com/proactive-vision-platform.html): Details on the blood-based AMD risk assessment platform
- [Publications](https://a1diagnosis.com/publications.html): Peer-reviewed research from the founding team
- [Validation Study](https://a1diagnosis.com/validation-study.html): Validation study design
- [Pipeline](https://a1diagnosis.com/pipeline.html): Multi-disease expansion roadmap beyond AMD
- [FAQs](https://a1diagnosis.com/faqs.html): Frequently asked questions about AMD and risk assessment
- [Early Risk Assessment](https://a1diagnosis.com/early-risk-assessment.html): Why early AMD risk assessment matters
- [AMD Stages](https://a1diagnosis.com/amd-stages.html): Stages and progression of macular degeneration
- [Risk Factors](https://a1diagnosis.com/risk-factors.html): Known risk factors for AMD
- [Treatment Landscape](https://a1diagnosis.com/treatment-landscape.html): Current and emerging AMD therapies

## About AMD

- Age-related macular degeneration is a leading cause of vision loss in people over 50
- AMD affects approximately 196 million people globally
- Early identification of risk may enable monitoring, lifestyle changes, and access to emerging preventive therapies
- Current detection typically occurs after vision loss has begun

## Disclaimer

This test has not been cleared or approved by the U.S. Food and Drug Administration.